AbbVie M21-446: A single arm open-label study to evaluate the efficacy and safety of ABBV-668 in Subjects with Moderate to Severe Ulcerative Colitis
Brief description of study
See protocol
Clinical Study Identifier: s22-01178
ClinicalTrials.gov Identifier: NCT05570006
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
